Genetic Variation, Vitamin D Metabolism, and Multiple Sclerosis: Understanding a Potential Gene–Environment Interaction

Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system whose development is influenced by both genetic susceptibility and environmental exposures. Among the environmental factors investigated, vitamin D has received considerable attention because higher dietary intake, greater sunlight exposure, residence at lower latitudes, and increased circulating concentrations of 25-hydroxyvitamin D have all been associated with a reduced risk of MS. Simon and colleagues examined whether genetic variation within the biological pathway responsible for vitamin D metabolism, transport, and cellular activity could help explain differences in susceptibility to MS. Their study, published in Multiple Sclerosis, specifically evaluated polymorphisms in genes encoding the vitamin D receptor and several proteins involved in the synthesis, degradation, and transport of vitamin D. Importantly, the investigators did not restrict their analysis to direct genetic effects. They also investigated whether genetic variants could alter the relationship between vitamin D exposure and MS risk, thereby addressing the broader possibility that environmental protection may depend on an individual's genetic background.

Biological Rationale for Investigating Vitamin D–Related Genes
The scientific rationale for the study arises from the highly regulated pathway through which vitamin D becomes biologically active. Vitamin D is initially converted in the liver to 25-hydroxyvitamin D, largely through the activity of the enzyme CYP2R1. It is subsequently converted by CYP27B1 into 1,25-dihydroxyvitamin D, the hormonally active form of vitamin D. This active metabolite binds to the vitamin D receptor (VDR), a nuclear receptor expressed in numerous tissues, including immune cells. Vitamin D metabolites are transported in circulation primarily by vitamin D binding protein (DBP), while CYP24A1 contributes to the degradation and regulation of active vitamin D metabolites. Variation in any of the genes encoding these proteins could theoretically influence vitamin D concentrations, receptor activity, immune regulation, or downstream gene expression. Because MS is characterized by abnormal immune activity directed against components of the central nervous system, genetically determined differences in vitamin D signaling represent a biologically plausible mechanism through which disease risk could be modified. The authors therefore examined polymorphisms in VDR, CYP27B1, CYP24A1, CYP2R1, and DBP as potential contributors to MS susceptibility.

Study Design and Genetic Analysis
The investigators conducted a nested case-control study using participants from two major prospective cohorts, the Nurses' Health Study and Nurses' Health Study II. The final analysis included 214 women with confirmed or probable MS and 428 age-matched controls without MS. The diagnosis of MS was validated through physicians and medical records, improving the reliability of case classification. Researchers analyzed a series of single-nucleotide polymorphisms, or SNPs, representing common genetic variations within the selected vitamin D-related genes. These included well-known VDR variants such as BsmI, ApaI, TaqI, FokI, and Cdx-2, in addition to polymorphisms in CYP27B1, CYP24A1, CYP2R1, and DBP. Genotyping quality was high, with complete concordance among blinded quality-control samples. Conditional logistic regression was then used to estimate relative risks and 95% confidence intervals. Beyond examining whether individual SNPs were independently associated with MS, the researchers tested interactions with dietary vitamin D intake, latitude of residence, and the established MS-associated genetic factor HLA-DR15, allowing the analysis to address both gene–environment and gene–gene relationships.

No Strong Independent Association Between the Selected SNPs and MS
A major finding was that none of the investigated vitamin D-related polymorphisms showed a statistically significant independent association with MS risk. Variants in VDR, CYP27B1, CYP24A1, CYP2R1, and DBP all produced effect estimates close to the null value, and none reached conventional statistical significance. Adjustment for HLA-DR15 did not materially alter these results, and the researchers also found no significant interactions between the vitamin D-related SNPs and HLA-DR15. These findings are scientifically important because they suggest that common variants in the selected genes are unlikely to exert large independent effects on MS susceptibility. However, a lack of statistically significant association should not be interpreted as evidence that vitamin D biology is irrelevant to MS. The study examined only selected variants rather than every possible polymorphism within these genes, and its sample size provided greater power to identify relatively large genetic effects than subtle ones. Consequently, smaller genetic effects or associations involving untested genomic regions could not be excluded. The findings therefore shift attention from a simple model of direct genetic causation toward a more complex model in which genetic variants may influence how individuals respond to environmental vitamin D exposure.

The FokI Variant Reveals a Possible Gene–Environment Interaction
The most notable result was a statistically significant interaction between dietary vitamin D intake and the VDR FokI polymorphism, with an interaction p-value of 0.04. When participants were stratified according to FokI genotype, increasing vitamin D intake was not associated with a reduced MS risk among women carrying the common FF genotype. In contrast, among women with the ff genotype, each 400 IU/day increase in vitamin D intake was associated with an estimated relative risk of approximately 0.21, corresponding to an approximately 79–80% reduction in risk. Women with the heterozygous Ff genotype demonstrated an intermediate association, suggesting a possible genotype-dependent gradient. The researchers also observed a broadly similar pattern when examining latitude of residence at age 15, with the protective association of residence farther south appearing stronger among carriers of the f allele, although this interaction did not reach statistical significance. Together, these observations suggest that the benefit associated with increased vitamin D exposure may not be uniform across the population and could depend partly on functional variation in the vitamin D receptor. A Possible Biological Explanation for the FokI Interaction
The FokI polymorphism is particularly interesting because it has functional consequences for the VDR protein. The variant affects the translation initiation site of the VDR gene, producing receptor proteins of different lengths. The F allele is associated with a shorter VDR protein that has been reported to possess greater transcriptional activity, whereas the f allele produces a receptor that is three amino acids longer and may exhibit comparatively reduced transcriptional activity. Simon and colleagues proposed a threshold model to explain their observations. Individuals carrying the more transcriptionally active receptor may require relatively modest vitamin D exposure to achieve sufficient downstream signaling, meaning that additional vitamin D provides little measurable protective advantage. By contrast, people carrying the less active receptor variant may require greater vitamin D exposure to achieve an equivalent level of vitamin D-mediated gene regulation. Higher vitamin D intake could therefore partially compensate for reduced receptor activity. Such a mechanism is biologically plausible because vitamin D signaling can influence immune-cell differentiation, inflammatory responses, and gene expression. Nevertheless, this explanation remains hypothetical; the epidemiological interaction identified in the study cannot by itself establish the molecular mechanism responsible.

Scientific Significance, Limitations, and Future Research
The study provides an instructive example of why complex diseases such as MS cannot always be understood by examining genetic and environmental risk factors independently. Although the selected vitamin D metabolism genes did not appear to substantially alter MS risk on their own, the possible interaction between dietary vitamin D and VDR FokI raises the possibility that genetic background determines the magnitude of an individual's response to vitamin D exposure. The authors appropriately emphasized several limitations. The study included a relatively small number of MS cases, reducing statistical power for detecting modest genetic effects and making interaction analyses particularly vulnerable to chance findings. The selected SNPs also did not comprehensively capture all genetic variation across the vitamin D pathway, and the cohort consisted predominantly of women of white ancestry, limiting generalizability to other populations. Most importantly, the FokI interaction was only marginally statistically significant and therefore requires independent replication. The broader contribution of the research is consequently not evidence that a particular genotype determines whether vitamin D prevents MS, but rather support for a more nuanced hypothesis: vitamin D exposure and genetic susceptibility may act together to influence MS development. Future studies with larger, more diverse populations, comprehensive genomic coverage, direct measurements of circulating vitamin D, and mechanistic investigation of VDR activity are necessary to determine whether this proposed gene–environment interaction represents a reproducible component of MS pathogenesis.

Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.

References:
Simon, K. C., Munger, K. L., Yang, X., & Ascherio, A. (2010). Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Multiple Sclerosis Journal, 16(2), 133-138.